Uremic encephalopathy: Difference between revisions
Ostermayer (talk | contribs) (Created page with "==Background== *Uremic encephalopathy is cerebral dysfunction caused by accumulation of uremic toxins due to acute kidney injury or chronic kidney disease<ref name="StatPearls">Olano CG, Akram SM, Hashmi MF, et al. Uremic Encephalopathy. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.</ref> *Typically develops when eGFR falls below '''15 mL/min''' (CKD Stage G5), though can occur at higher eGFR in acute kidney injury where the rate of de...") |
(Formatting: removed bold) |
||
| Line 3: | Line 3: | ||
*Typically develops when eGFR falls below '''15 mL/min''' (CKD Stage G5), though can occur at higher eGFR in acute kidney injury where the rate of decline is rapid<ref name="Rosner2022">Rosner MH, Husain-Syed F, Reis T, Ronco C, Vanholder R. Uremic encephalopathy. Kidney Int. 2022;101(2):227-241.</ref> | *Typically develops when eGFR falls below '''15 mL/min''' (CKD Stage G5), though can occur at higher eGFR in acute kidney injury where the rate of decline is rapid<ref name="Rosner2022">Rosner MH, Husain-Syed F, Reis T, Ronco C, Vanholder R. Uremic encephalopathy. Kidney Int. 2022;101(2):227-241.</ref> | ||
*Severity correlates with the '''rate of decline''' in kidney function — AKI causes more severe encephalopathy than progressive CKD at the same GFR, because chronic adaptation has not occurred | *Severity correlates with the '''rate of decline''' in kidney function — AKI causes more severe encephalopathy than progressive CKD at the same GFR, because chronic adaptation has not occurred | ||
* | *Reversible with dialysis — this is both the treatment and the diagnostic confirmation; uremic encephalopathy is an '''absolute indication''' for emergent renal replacement therapy<ref name="StatPearls"/> | ||
* | *Diagnosis of exclusion — there is no confirmatory test; the diagnosis is often made retrospectively when mental status improves after dialysis<ref name="Rosner2022"/> | ||
*Pathophysiology is multifactorial: accumulation of uremic solutes (urea, guanidino compounds, indoxyl sulfate, p-cresol, PTH), disruption of the blood-brain barrier, neurotransmitter imbalances (↑ GABA, altered dopamine/serotonin), electrolyte derangements, and systemic inflammation | *Pathophysiology is multifactorial: accumulation of uremic solutes (urea, guanidino compounds, indoxyl sulfate, p-cresol, PTH), disruption of the blood-brain barrier, neurotransmitter imbalances (↑ GABA, altered dopamine/serotonin), electrolyte derangements, and systemic inflammation | ||
*Can also occur in dialysis patients receiving '''inadequate dialysis''' (noncompliance, AV fistula dysfunction, underdialysis) | *Can also occur in dialysis patients receiving '''inadequate dialysis''' (noncompliance, AV fistula dysfunction, underdialysis) | ||
| Line 20: | Line 20: | ||
===Moderate=== | ===Moderate=== | ||
* | *[[Altered mental status]]: confusion, disorientation, delirium | ||
*[[Asterixis]] ('''flapping tremor''' — highly suggestive but not pathognomonic; also seen in hepatic encephalopathy, hypercapnia, drug toxicity) | *[[Asterixis]] ('''flapping tremor''' — highly suggestive but not pathognomonic; also seen in hepatic encephalopathy, hypercapnia, drug toxicity) | ||
*Myoclonus (multifocal muscle jerking) | *Myoclonus (multifocal muscle jerking) | ||
| Line 29: | Line 29: | ||
===Severe=== | ===Severe=== | ||
* | *[[Seizures]] (generalized tonic-clonic or myoclonic; more common in AKI than CKD) | ||
*Stupor | *Stupor | ||
* | *Coma | ||
*Opisthotonus (rare) | *Opisthotonus (rare) | ||
===ED Pearls=== | ===ED Pearls=== | ||
* | *Asterixis + elevated BUN/creatinine + no prior known liver disease = think uremic encephalopathy | ||
*Symptoms in CKD patients are often '''subtle and progressive''' — family may report gradual personality changes, forgetfulness, or increased confusion over days to weeks | *Symptoms in CKD patients are often '''subtle and progressive''' — family may report gradual personality changes, forgetfulness, or increased confusion over days to weeks | ||
*In AKI, encephalopathy can develop '''rapidly''' (hours to days) and may be the presenting feature | *In AKI, encephalopathy can develop '''rapidly''' (hours to days) and may be the presenting feature | ||
*A dialysis patient presenting with AMS should be evaluated for '''both''' uremic encephalopathy (inadequate dialysis) '''and''' dialysis disequilibrium syndrome (too-rapid dialysis) — timing relative to last dialysis session is key | *A dialysis patient presenting with AMS should be evaluated for '''both''' uremic encephalopathy (inadequate dialysis) '''and''' dialysis disequilibrium syndrome (too-rapid dialysis) — timing relative to last dialysis session is key | ||
*Uremic encephalopathy may '''paradoxically improve arthritis''' symptoms in patients with concurrent rheumatic disease — decreased activity is sometimes misinterpreted as clinical improvement | *Uremic encephalopathy may '''paradoxically improve arthritis''' symptoms in patients with concurrent rheumatic disease — decreased activity is sometimes misinterpreted as clinical improvement | ||
* | *Seizures in CKD/ESRD patients should prompt evaluation for uremia, but also for [[hypertensive encephalopathy]], [[hypoglycemia]], [[hyponatremia]], [[hypocalcemia]], [[hypermagnesemia]], and medication toxicity | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
| Line 46: | Line 46: | ||
===Metabolic/Toxic=== | ===Metabolic/Toxic=== | ||
* | *[[Hyperkalemia]] (can cause weakness, paralysis, and obtundation in addition to cardiac effects) | ||
* | *[[Hyponatremia]] or '''[[hypernatremia]]''' | ||
* | *[[Hypoglycemia]] or '''[[hyperglycemia]]''' / [[hyperosmolar coma]] | ||
* | *[[Hypercalcemia]] | ||
* | *[[Hypermagnesemia]] (especially in CKD patients taking Mg-containing antacids) | ||
* | *[[Hepatic encephalopathy]] (concomitant liver disease is common) | ||
* | *Medication toxicity: [[opioids]] (accumulate in CKD), [[benzodiazepines]], [[gabapentin]]/[[pregabalin]], [[lithium]], [[metformin]] (lactic acidosis) | ||
* | *Severe [[metabolic acidosis]] | ||
* | *[[Wernicke encephalopathy]] (thiamine deficiency — may coexist in malnourished CKD patients) | ||
===Structural/Vascular=== | ===Structural/Vascular=== | ||
* | *[[Stroke (Main)|Stroke]] (CKD patients have high cerebrovascular risk) | ||
* | *[[Subdural hematoma]] (uremic patients have impaired platelet function; anticoagulation for dialysis access) | ||
* | *[[Intracranial hemorrhage]] | ||
* | *[[Hypertensive encephalopathy]] / [[PRES]] (posterior reversible encephalopathy syndrome) | ||
===Infectious=== | ===Infectious=== | ||
* | *[[Sepsis (Main)|Sepsis]] (dialysis access infection, [[pneumonia]], [[UTI]]) — '''most important to exclude immediately''' | ||
* | *[[Meningitis]]/[[encephalitis]] | ||
===Dialysis-Related=== | ===Dialysis-Related=== | ||
* | *[[Dialysis complications|Dialysis disequilibrium syndrome]]: Headache, nausea, AMS, seizures occurring '''during or shortly after''' dialysis (especially first sessions or aggressive ultrafiltration); caused by rapid osmolar shifts and cerebral edema | ||
* | *Osmotic demyelination syndrome (from rapid correction of [[hyponatremia]]) | ||
* | *Aluminum toxicity (historical; rare with modern dialysate) | ||
{{AMS DDX}} | {{AMS DDX}} | ||
| Line 77: | Line 77: | ||
''The workup is directed at confirming severe renal dysfunction AND excluding mimickers. It must be rapid.'' | ''The workup is directed at confirming severe renal dysfunction AND excluding mimickers. It must be rapid.'' | ||
* | *BMP/CMP: BUN, creatinine (compare to baseline), electrolytes (K⁺, Na⁺, Ca²⁺, Mg²⁺, phosphorus), glucose, bicarbonate (anion gap) | ||
**BUN is typically '''markedly elevated''' (often >100-150 mg/dL); however, there is no absolute BUN threshold that defines uremic encephalopathy | **BUN is typically '''markedly elevated''' (often >100-150 mg/dL); however, there is no absolute BUN threshold that defines uremic encephalopathy | ||
* | *CBC: Leukocytosis (suggests infection); anemia (baseline in CKD, acute worsening suggests bleed) | ||
* | *VBG or ABG: Assess acid-base status and calculate anion gap; severe uremic acidosis may coexist | ||
* | *[[Lactate]]: Evaluate for sepsis or tissue hypoperfusion | ||
* | *Ammonia: If hepatic encephalopathy is also being considered (common in patients with combined liver/kidney disease) | ||
* | *Fingerstick glucose: Immediate — rule out [[hypoglycemia]] | ||
* | *[[ECG]]: Evaluate for [[hyperkalemia]] (peaked T waves, wide QRS), [[QT prolongation]] | ||
* | *Toxicology screen: Exclude drug intoxication | ||
* | *Serum osmolality: Assess for hyperosmolar states or osmolar gap (toxic alcohol) | ||
* | *PTH, magnesium: Hyperparathyroidism and hypermagnesemia can both contribute to metabolic encephalopathy | ||
* | *[[CXR]]: Evaluate for volume overload, infection | ||
* | *Blood cultures: If any suspicion for [[sepsis]] (dialysis patients are high risk for bloodstream infection) | ||
* | *[[CT head]] without contrast: To exclude [[intracranial hemorrhage]], [[subdural hematoma]], mass lesion, or signs of cerebral edema | ||
**MRI is more sensitive (may show bilateral basal ganglia involvement — "lentiform fork sign" — or cortical/white matter changes) but is not required emergently | **MRI is more sensitive (may show bilateral basal ganglia involvement — "lentiform fork sign" — or cortical/white matter changes) but is not required emergently | ||
* | *[[LP]]: Not routinely needed; consider if clinical picture does not improve after dialysis or if there is concern for [[meningitis]]/[[encephalitis]] | ||
* | *EEG: Not required in the ED; shows diffuse slowing proportional to the severity of renal dysfunction; may be useful if subclinical seizures are suspected | ||
===Diagnosis=== | ===Diagnosis=== | ||
* | *Diagnosis of exclusion — no single confirmatory test exists<ref name="Rosner2022"/> | ||
*Clinical diagnosis is based on: | *Clinical diagnosis is based on: | ||
** | **Significantly impaired renal function (eGFR <15, markedly elevated BUN/creatinine) | ||
** | **Compatible neurologic findings (progressive AMS, asterixis, myoclonus, seizures) | ||
** | **Exclusion of other causes of altered mental status | ||
** | **Improvement after initiation of dialysis (the most definitive diagnostic confirmation — but do not wait for this to begin treatment) | ||
* | *ED diagnostic pearl: The combination of '''asterixis''' + '''BUN >100''' + '''no hepatic disease''' + '''no structural lesion on CT''' in a patient with known CKD or AKI is highly suggestive | ||
*If neurologic status does not improve after 3-5 dialysis sessions, '''re-evaluate for alternative or additional diagnoses'''<ref name="Rosner2022"/> | *If neurologic status does not improve after 3-5 dialysis sessions, '''re-evaluate for alternative or additional diagnoses'''<ref name="Rosner2022"/> | ||
==Management== | ==Management== | ||
===Resuscitation and Stabilization=== | ===Resuscitation and Stabilization=== | ||
* | *ABCs: Airway protection is critical — obtunded patients may need [[intubation]] (use medications that do not require renal clearance for RSI; consider [[rocuronium]] over [[succinylcholine]] if [[hyperkalemia]] is present or suspected) | ||
* | *IV access: If patient does not already have dialysis access, '''emergent dialysis catheter placement''' will be needed | ||
* | *Continuous monitoring: telemetry, pulse oximetry, frequent neuro checks | ||
* | *Treat concurrent [[hyperkalemia]]: [[Calcium gluconate]], [[insulin]]/D50, nebulized [[albuterol]] (see [[Hyperkalemia]]) | ||
* | *Treat concurrent [[metabolic acidosis]]: [[Sodium bicarbonate]] for pH <7.1 or hemodynamic instability | ||
* | *Treat concurrent volume overload: [[Nitroglycerin]], high-dose [[furosemide]], [[BiPAP]] (see [[Pulmonary edema]]) | ||
===Definitive Treatment: Emergent Dialysis=== | ===Definitive Treatment: Emergent Dialysis=== | ||
*'''Uremic encephalopathy is an absolute indication for emergent renal replacement therapy'''<ref name="StatPearls"/> | *'''Uremic encephalopathy is an absolute indication for emergent renal replacement therapy'''<ref name="StatPearls"/> | ||
* | *Hemodialysis is the most common modality in the ED setting | ||
*Initiate with '''gentle parameters''' to reduce risk of '''dialysis disequilibrium syndrome:'''<ref name="Rosner2022"/> | *Initiate with '''gentle parameters''' to reduce risk of '''dialysis disequilibrium syndrome:'''<ref name="Rosner2022"/> | ||
**Lower blood flow rates (200-300 mL/min) | **Lower blood flow rates (200-300 mL/min) | ||
| Line 122: | Line 122: | ||
**Shorter initial session (2-3 hours rather than standard 4 hours) | **Shorter initial session (2-3 hours rather than standard 4 hours) | ||
**Avoid large rapid shifts in plasma osmolality | **Avoid large rapid shifts in plasma osmolality | ||
* | *CRRT (continuous renal replacement therapy) may be preferred in hemodynamically unstable patients (ICU setting) | ||
* | *Peritoneal dialysis is an alternative if hemodialysis is not available or vascular access cannot be obtained | ||
*Clinical improvement is typically seen within '''24-48 hours''' of initiating adequate dialysis, though full neurologic recovery may take days to weeks | *Clinical improvement is typically seen within '''24-48 hours''' of initiating adequate dialysis, though full neurologic recovery may take days to weeks | ||
*EEG abnormalities may persist for months even after clinical improvement | *EEG abnormalities may persist for months even after clinical improvement | ||
===Seizure Management=== | ===Seizure Management=== | ||
* | *[[Levetiracetam]] (Keppra) is the preferred antiepileptic in renal failure (dose-adjust; well tolerated) | ||
* | *[[Benzodiazepines]] ([[lorazepam]], [[midazolam]]) for acute seizure termination | ||
* | *Avoid [[phenytoin]] — highly protein-bound; levels are unreliable in CKD/ESRD (altered protein binding, renal clearance of metabolites); if must use, monitor free phenytoin levels | ||
*Seizures may resolve with '''dialysis alone''' once uremia is corrected | *Seizures may resolve with '''dialysis alone''' once uremia is corrected | ||
*'''Do not use [[succinylcholine]]''' for intubation in seizing CKD patients — risk of exacerbating hyperkalemia | *'''Do not use [[succinylcholine]]''' for intubation in seizing CKD patients — risk of exacerbating hyperkalemia | ||
| Line 136: | Line 136: | ||
===Uremic Bleeding Considerations=== | ===Uremic Bleeding Considerations=== | ||
*If procedures are needed (dialysis catheter, LP, intubation), be aware of '''uremic platelet dysfunction''' | *If procedures are needed (dialysis catheter, LP, intubation), be aware of '''uremic platelet dysfunction''' | ||
* | *[[DDAVP]] 0.3 mcg/kg IV — first-line to transiently improve platelet function | ||
*See [[Chronic kidney disease]] for full uremic bleeding management | *See [[Chronic kidney disease]] for full uremic bleeding management | ||
===Consultations=== | ===Consultations=== | ||
* | *Nephrology: Emergent — for dialysis initiation and ongoing management | ||
* | *Critical care/ICU: Most patients with uremic encephalopathy require ICU admission | ||
* | *Neurology: If diagnosis is uncertain, seizures are refractory, or mental status does not improve after dialysis | ||
* | *Interventional radiology or surgery: If emergent dialysis catheter placement is needed | ||
==Disposition== | ==Disposition== | ||
* | *ICU admission for nearly all patients with uremic encephalopathy: | ||
**Requires emergent dialysis with close hemodynamic monitoring | **Requires emergent dialysis with close hemodynamic monitoring | ||
**Risk of seizures, airway compromise, arrhythmias from concurrent hyperkalemia | **Risk of seizures, airway compromise, arrhythmias from concurrent hyperkalemia | ||
**Risk of dialysis disequilibrium syndrome during initial treatments | **Risk of dialysis disequilibrium syndrome during initial treatments | ||
*'''Do not discharge''' patients with suspected uremic encephalopathy | *'''Do not discharge''' patients with suspected uremic encephalopathy | ||
* | *Reassess diagnosis if mental status does not improve after 3-5 dialysis sessions — consider structural lesion, ongoing infection, or alternative metabolic derangement<ref name="Rosner2022"/> | ||
*For patients with known ESRD presenting with mild cognitive changes that improve after routine dialysis, discharge may be appropriate with '''close nephrology follow-up''' and evaluation for adequacy of dialysis (Kt/V measurement, access evaluation) | *For patients with known ESRD presenting with mild cognitive changes that improve after routine dialysis, discharge may be appropriate with '''close nephrology follow-up''' and evaluation for adequacy of dialysis (Kt/V measurement, access evaluation) | ||
Revision as of 16:12, 19 March 2026
Background
- Uremic encephalopathy is cerebral dysfunction caused by accumulation of uremic toxins due to acute kidney injury or chronic kidney disease[1]
- Typically develops when eGFR falls below 15 mL/min (CKD Stage G5), though can occur at higher eGFR in acute kidney injury where the rate of decline is rapid[2]
- Severity correlates with the rate of decline in kidney function — AKI causes more severe encephalopathy than progressive CKD at the same GFR, because chronic adaptation has not occurred
- Reversible with dialysis — this is both the treatment and the diagnostic confirmation; uremic encephalopathy is an absolute indication for emergent renal replacement therapy[1]
- Diagnosis of exclusion — there is no confirmatory test; the diagnosis is often made retrospectively when mental status improves after dialysis[2]
- Pathophysiology is multifactorial: accumulation of uremic solutes (urea, guanidino compounds, indoxyl sulfate, p-cresol, PTH), disruption of the blood-brain barrier, neurotransmitter imbalances (↑ GABA, altered dopamine/serotonin), electrolyte derangements, and systemic inflammation
- Can also occur in dialysis patients receiving inadequate dialysis (noncompliance, AV fistula dysfunction, underdialysis)
Clinical Features
The clinical spectrum ranges from subtle cognitive changes to coma. Progression is inevitable without treatment.
Early/Mild
- Fatigue, malaise, poor concentration
- Insomnia, sleep-wake cycle disturbance
- Irritability, emotional lability
- Anorexia, nausea
- Impaired memory, difficulty with complex tasks
- Apathy, withdrawal
Moderate
- Altered mental status: confusion, disorientation, delirium
- Asterixis (flapping tremor — highly suggestive but not pathognomonic; also seen in hepatic encephalopathy, hypercapnia, drug toxicity)
- Myoclonus (multifocal muscle jerking)
- Tremor
- Dysarthria
- Ataxia, gait instability
- Hyperreflexia
Severe
- Seizures (generalized tonic-clonic or myoclonic; more common in AKI than CKD)
- Stupor
- Coma
- Opisthotonus (rare)
ED Pearls
- Asterixis + elevated BUN/creatinine + no prior known liver disease = think uremic encephalopathy
- Symptoms in CKD patients are often subtle and progressive — family may report gradual personality changes, forgetfulness, or increased confusion over days to weeks
- In AKI, encephalopathy can develop rapidly (hours to days) and may be the presenting feature
- A dialysis patient presenting with AMS should be evaluated for both uremic encephalopathy (inadequate dialysis) and dialysis disequilibrium syndrome (too-rapid dialysis) — timing relative to last dialysis session is key
- Uremic encephalopathy may paradoxically improve arthritis symptoms in patients with concurrent rheumatic disease — decreased activity is sometimes misinterpreted as clinical improvement
- Seizures in CKD/ESRD patients should prompt evaluation for uremia, but also for hypertensive encephalopathy, hypoglycemia, hyponatremia, hypocalcemia, hypermagnesemia, and medication toxicity
Differential Diagnosis
All other causes of altered mental status must be considered and excluded before attributing encephalopathy to uremia alone:
Metabolic/Toxic
- Hyperkalemia (can cause weakness, paralysis, and obtundation in addition to cardiac effects)
- Hyponatremia or hypernatremia
- Hypoglycemia or hyperglycemia / hyperosmolar coma
- Hypercalcemia
- Hypermagnesemia (especially in CKD patients taking Mg-containing antacids)
- Hepatic encephalopathy (concomitant liver disease is common)
- Medication toxicity: opioids (accumulate in CKD), benzodiazepines, gabapentin/pregabalin, lithium, metformin (lactic acidosis)
- Severe metabolic acidosis
- Wernicke encephalopathy (thiamine deficiency — may coexist in malnourished CKD patients)
Structural/Vascular
- Stroke (CKD patients have high cerebrovascular risk)
- Subdural hematoma (uremic patients have impaired platelet function; anticoagulation for dialysis access)
- Intracranial hemorrhage
- Hypertensive encephalopathy / PRES (posterior reversible encephalopathy syndrome)
Infectious
- Sepsis (dialysis access infection, pneumonia, UTI) — most important to exclude immediately
- Meningitis/encephalitis
Dialysis-Related
- Dialysis disequilibrium syndrome: Headache, nausea, AMS, seizures occurring during or shortly after dialysis (especially first sessions or aggressive ultrafiltration); caused by rapid osmolar shifts and cerebral edema
- Osmotic demyelination syndrome (from rapid correction of hyponatremia)
- Aluminum toxicity (historical; rare with modern dialysate)
Altered mental status
Diffuse brain dysfunction
- Hypoxic encephalopathy
- Acute toxic-metabolic encephalopathy (Delirium)
- Hypoglycemia
- Hyperosmolar state (e.g., hyperglycemia)
- Electrolyte Abnormalities (hypernatremia or hyponatremia, hypercalcemia)
- Organ system failure
- Hepatic Encephalopathy
- Uremia/Renal Failure
- Endocrine (Addison's disease, Cushing syndrome, hypothyroidism, myxedema coma, thyroid storm)
- Hypoxia
- CO2 narcosis
- Hypertensive Encephalopathy
- Toxins
- TTP / Thrombotic thrombocytopenic purpura
- Alcohol withdrawal
- Drug reactions (NMS, Serotonin Syndrome)
- Environmental causes
- Deficiency state
- Wernicke encephalopathy
- Subacute Combined Degeneration of Spinal Cord (B12 deficiency)
- Vitamin D Deficiency
- Zinc Deficiency
- Sepsis
- Osmotic demyelination syndrome (central pontine myelinolysis)
- Limbic encephalitis
Primary CNS disease or trauma
- Direct CNS trauma
- Diffuse axonal injury
- Subdural/epidural hematoma
- Vascular disease
- SAH
- Stroke
- Hemispheric, brainstem
- CNS infections
- Neoplasms
- Paraneoplastic Limbic encephalitis
- Malignant Meningitis
- Pancreatic Insulinoma
- Seizures
- Nonconvulsive status epilepticus
- Postictal state
- Dementia
Psychiatric
Evaluation
Workup
The workup is directed at confirming severe renal dysfunction AND excluding mimickers. It must be rapid.
- BMP/CMP: BUN, creatinine (compare to baseline), electrolytes (K⁺, Na⁺, Ca²⁺, Mg²⁺, phosphorus), glucose, bicarbonate (anion gap)
- BUN is typically markedly elevated (often >100-150 mg/dL); however, there is no absolute BUN threshold that defines uremic encephalopathy
- CBC: Leukocytosis (suggests infection); anemia (baseline in CKD, acute worsening suggests bleed)
- VBG or ABG: Assess acid-base status and calculate anion gap; severe uremic acidosis may coexist
- Lactate: Evaluate for sepsis or tissue hypoperfusion
- Ammonia: If hepatic encephalopathy is also being considered (common in patients with combined liver/kidney disease)
- Fingerstick glucose: Immediate — rule out hypoglycemia
- ECG: Evaluate for hyperkalemia (peaked T waves, wide QRS), QT prolongation
- Toxicology screen: Exclude drug intoxication
- Serum osmolality: Assess for hyperosmolar states or osmolar gap (toxic alcohol)
- PTH, magnesium: Hyperparathyroidism and hypermagnesemia can both contribute to metabolic encephalopathy
- CXR: Evaluate for volume overload, infection
- Blood cultures: If any suspicion for sepsis (dialysis patients are high risk for bloodstream infection)
- CT head without contrast: To exclude intracranial hemorrhage, subdural hematoma, mass lesion, or signs of cerebral edema
- MRI is more sensitive (may show bilateral basal ganglia involvement — "lentiform fork sign" — or cortical/white matter changes) but is not required emergently
- LP: Not routinely needed; consider if clinical picture does not improve after dialysis or if there is concern for meningitis/encephalitis
- EEG: Not required in the ED; shows diffuse slowing proportional to the severity of renal dysfunction; may be useful if subclinical seizures are suspected
Diagnosis
- Diagnosis of exclusion — no single confirmatory test exists[2]
- Clinical diagnosis is based on:
- Significantly impaired renal function (eGFR <15, markedly elevated BUN/creatinine)
- Compatible neurologic findings (progressive AMS, asterixis, myoclonus, seizures)
- Exclusion of other causes of altered mental status
- Improvement after initiation of dialysis (the most definitive diagnostic confirmation — but do not wait for this to begin treatment)
- ED diagnostic pearl: The combination of asterixis + BUN >100 + no hepatic disease + no structural lesion on CT in a patient with known CKD or AKI is highly suggestive
- If neurologic status does not improve after 3-5 dialysis sessions, re-evaluate for alternative or additional diagnoses[2]
Management
Resuscitation and Stabilization
- ABCs: Airway protection is critical — obtunded patients may need intubation (use medications that do not require renal clearance for RSI; consider rocuronium over succinylcholine if hyperkalemia is present or suspected)
- IV access: If patient does not already have dialysis access, emergent dialysis catheter placement will be needed
- Continuous monitoring: telemetry, pulse oximetry, frequent neuro checks
- Treat concurrent hyperkalemia: Calcium gluconate, insulin/D50, nebulized albuterol (see Hyperkalemia)
- Treat concurrent metabolic acidosis: Sodium bicarbonate for pH <7.1 or hemodynamic instability
- Treat concurrent volume overload: Nitroglycerin, high-dose furosemide, BiPAP (see Pulmonary edema)
Definitive Treatment: Emergent Dialysis
- Uremic encephalopathy is an absolute indication for emergent renal replacement therapy[1]
- Hemodialysis is the most common modality in the ED setting
- Initiate with gentle parameters to reduce risk of dialysis disequilibrium syndrome:[2]
- Lower blood flow rates (200-300 mL/min)
- Lower dialysate flow rates (400-600 mL/min)
- Shorter initial session (2-3 hours rather than standard 4 hours)
- Avoid large rapid shifts in plasma osmolality
- CRRT (continuous renal replacement therapy) may be preferred in hemodynamically unstable patients (ICU setting)
- Peritoneal dialysis is an alternative if hemodialysis is not available or vascular access cannot be obtained
- Clinical improvement is typically seen within 24-48 hours of initiating adequate dialysis, though full neurologic recovery may take days to weeks
- EEG abnormalities may persist for months even after clinical improvement
Seizure Management
- Levetiracetam (Keppra) is the preferred antiepileptic in renal failure (dose-adjust; well tolerated)
- Benzodiazepines (lorazepam, midazolam) for acute seizure termination
- Avoid phenytoin — highly protein-bound; levels are unreliable in CKD/ESRD (altered protein binding, renal clearance of metabolites); if must use, monitor free phenytoin levels
- Seizures may resolve with dialysis alone once uremia is corrected
- Do not use succinylcholine for intubation in seizing CKD patients — risk of exacerbating hyperkalemia
Uremic Bleeding Considerations
- If procedures are needed (dialysis catheter, LP, intubation), be aware of uremic platelet dysfunction
- DDAVP 0.3 mcg/kg IV — first-line to transiently improve platelet function
- See Chronic kidney disease for full uremic bleeding management
Consultations
- Nephrology: Emergent — for dialysis initiation and ongoing management
- Critical care/ICU: Most patients with uremic encephalopathy require ICU admission
- Neurology: If diagnosis is uncertain, seizures are refractory, or mental status does not improve after dialysis
- Interventional radiology or surgery: If emergent dialysis catheter placement is needed
Disposition
- ICU admission for nearly all patients with uremic encephalopathy:
- Requires emergent dialysis with close hemodynamic monitoring
- Risk of seizures, airway compromise, arrhythmias from concurrent hyperkalemia
- Risk of dialysis disequilibrium syndrome during initial treatments
- Do not discharge patients with suspected uremic encephalopathy
- Reassess diagnosis if mental status does not improve after 3-5 dialysis sessions — consider structural lesion, ongoing infection, or alternative metabolic derangement[2]
- For patients with known ESRD presenting with mild cognitive changes that improve after routine dialysis, discharge may be appropriate with close nephrology follow-up and evaluation for adequacy of dialysis (Kt/V measurement, access evaluation)
See Also
- Chronic kidney disease
- Acute kidney injury
- Dialysis complications
- Hyperkalemia
- Metabolic acidosis
- Altered mental status
- Hepatic encephalopathy
- Hypertensive emergency
- Seizure